SFTI-KLK7
SFTI-KLK7 is a KLK7 inhibitor, with Ki 0.14 nM[1].
Product Specifications
UNSPSC
12352209
Target
Others
Related Pathways
Others
Field of Research
Inflammation/Immunology
Smiles
O=C(N[C@@H](CCCCN)C(N[C@@H](CSSC[C@@H](C(N[C@@H](CC1=CC=CC=C1)C(N2[C@@H](CCC2)C(N[C@@H](CC(N)=O)C(O)=O)=O)=O)=O)NC3=O)C(N[C@@H](CC(C)C)C(N[C@@H](CC4=CC=CC=C4)C(N[C@@H](CO)C(N[C@@H](CC(N)=O)C(N5[C@@H](CCC5)C(N6[C@@H](CCC6)C(N[C@H]3[C@@H](C)CC)=O)=O)=O)=O)=O)=O)=O)=O)CN
Molecular Formula
C70H103N17O18S2
Molecular Weight
1534.80
References & Citations
[1]de Veer SJ, Furio L, et al. Selective Substrates and Inhibitors for Kallikrein-Related Peptidase 7 (KLK7) Shed Light on KLK Proteolytic Activity in the Stratum Corneum. J Invest Dermatol. 2017 Feb;137 (2) :430-439.
Shipping Conditions
Room temperature
Scientific Category
Peptides
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
PC1015263-01 250 mg
6-Bromo-2-chloro-3- (trifluoromethoxy) benzaldehyde
Sign In for Pricing
View Details PC1015263-02 500 mg
6-Bromo-2-chloro-3- (trifluoromethoxy) benzaldehyde
Sign In for Pricing
View Details PC1015263-03 1 g
6-Bromo-2-chloro-3- (trifluoromethoxy) benzaldehyde
Sign In for Pricing
View Details MBS6258791-01 0.1 mL
CD146 (Mucin 18, MUC18 Glycoprotein, Melanoma Associated Antigen A32, S-endo 1 Endothelial Associated Antigen, Melanoma Adhesion Molecule Mel-CM) (HRP)
Sign In for Pricing
View Details MBS6258791-02 5x 0.1 mL
CD146 (Mucin 18, MUC18 Glycoprotein, Melanoma Associated Antigen A32, S-endo 1 Endothelial Associated Antigen, Melanoma Adhesion Molecule Mel-CM) (HRP)
Sign In for Pricing
View Details